z-logo
open-access-imgOpen Access
KIF4A: A potential biomarker for prediction and prognostic of prostate cancer
Author(s) -
Jiahong Chen,
Maozhang Li,
Shumin Fang,
Xiaobo Zhou,
Jinxian Liao,
ShengBang Yang,
Jianguo Zhu,
Renqiang He,
Jianming Lü,
Funeng Jiang,
Xiaoming Xu,
Weide Zhong
Publication year - 2020
Publication title -
clinical and investigative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.391
H-Index - 47
eISSN - 1488-2353
pISSN - 0147-958X
DOI - 10.25011/cim.v43i3.34393
Subject(s) - du145 , prostate cancer , lncap , oncology , medicine , cancer research , apoptosis , biochemical recurrence , cancer , prostatectomy , biology , biochemistry
Purpose: To investigate the clinical relevance and biological function of the kinesin super-family protein 4A (KIF4A) expression in prostate cancer (PCa). Methods: We examined 1) the relationship between the expression of KIF4A and clinico-pathological characteristics of PCa patients using a tissue microarray and the Cancer Genome Atlas database, 2) the prognostic value of KIF4A expression in patients using Kaplan-Meier plots and 3) the functions of KIF4A in LNCaP and DU145 cells, such as cell proliferation, cell cycle and cell apoptosis. Results: Compared with normal prostate, the mRNA and protein expressions of KIF4A were up-regulated in PCa. The up-regulation expression rates of KIF4A in PCa were significantly related to the Gleason score (P

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here